Epicardial adipose tissue (EAT) volume and attenuation are associated with cardiovascular risk, but manual annotation is time-consuming. We evaluated whether automated deep learning-based EAT measurements from ungated computed tomography (CT) are associated with death…
Continue Reading
Discover how the FDA-cleared Vivio System by Ventric Health is reshaping heart failure diagnosis and management. With advanced algorithms for noninvasive diagnosis, this innovative cardiac device brings timely interventions to home and outpatient settings….
Continue Reading
Tech-enabled heart disease detection company CardioSignal announced it secured $10 million in Series A funding, bringing its total raise to $23 million. DigiTx Partners led the round. Sandwater also participated alongside existing investor Maki.vc.
Dr. David…
Heart failure affects 6.5 million people in the U.S., with an additional 550,000 newly diagnosed each year. Heart failure hospitalizations are a leading cause of admissions for those 65 and older, totaling hundreds of…
Continue Reading
What You Should Know:
– Harris, a global leader in vertical market software, has acquired the Medstreaming software suite from Fivos. Financial details of the acquisition were not disclosed.
– The acquisition of Medstreaming by Harris…
Continue Reading
Assessment of left ventricular diastolic function plays a major role in the diagnosis and prognosis of cardiac diseases, including heart failure with preserved ejection fraction. We aimed to develop an artificial intelligence (AI)-enabled electrocardiogram…
Continue Reading
Background: Anticoagulation management can effectively prevent complications in patients undergoing cardiac valve replacement (CVR). The emergence of eHealth tools provides new prospects for the management of long-term anticoagulants. However, there is no comprehensive summary…
Continue Reading
Stuart Long, CEO, InfoBionic
Cardiac Health is Top of Mind. The Quest to ‘Zero’ Avoidable Cardiac-Related Deaths Continues.
Cardiac disease is one of the top health concerns in the United States. According to the Centers for…
Continue Reading
Kaiser Permanente’s AIM-HI grants $750,000 to five healthcare projects exploring AI and ML’s impact on patient care. From pediatric asthma to cardiac amyloidosis, these initiatives aim to revolutionize healthcare practices. This funding, backed by…
Continue Reading
LUMA Vision’s VERAFEYE platform, backed by a $22 million Series A3 financing, revolutionizes cardiac imaging. Employing 4D technology and machine learning, it offers real-time soft tissue imaging for precise intracardiac navigation. With funding from…
Continue Reading
